A glimpse into novel acylations and their emerging role in regulating cancer metastasis

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Metastatic cancer is a leading cause of cancer mortality, with complex regulatory mechanisms requiring further elucidation.
• Epigenetic mechanisms, particularly posttranslational modifications (PTMs) of proteins, are increasingly recognized for their critical role in cancer malignancy.
• Recent advances in mass spectrometry and proteomics have identified novel forms of protein acylation beyond acetylation.

Purpose of the Study:

• To comprehensively review the identification and characterization of 11 novel acylations and their modifying enzymes.
• To highlight the significance of these novel acylations in regulating cancer metastasis.
• To explore the potential of these acylations and enzymes as clinical therapeutic targets and diagnostic predictors for tumors.

Main Methods:

• Review of recent literature on novel acylation types and their associated enzymes.
• Analysis of mass spectrometry, proteomics, and bioinformatics data for characterization.
• Discussion of the functional roles in energy metabolism and signal transduction.

Main Results:

• Identification and characterization of 11 novel acylations (e.g., propionylation, butyrylation, lactylation).
• Demonstration of these acylations covalently modifying histone and nonhistone proteins.
• Evidence for their involvement in regulating energy metabolism and signal transduction pathways.

Conclusions:

• Novel acylations represent a significant class of epigenetic regulators in cancer metastasis.
• These modifications and their enzymes hold considerable promise for the diagnosis and treatment of metastatic tumors.
• Further research is needed to overcome current obstacles and fully realize their clinical potential.